R. Menon
4 Papers
R. Menon is an academic researcher. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 1, co-authored 4 publications.
Chat about Author
Papers
Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis.
Laura H. Mariani,Sean Eddy,Fadhl M. Al-Akwaa,Phillip J. McCown,Jennifer L. Harder,Viji Nair,Felix Eichinger,Sebastian Martini,Adebowale D. Ademola,Vincent Boima,Heather N. Reich,Jamal El Saghir,Bradley Godfrey,Wenjun Ju,E. Tanner,Virginia Vega-Warner,Noel L. Wys,Sharon G. Adler,Gerald B. Appel,Ambarish M. Athavale,Meredith A. Atkinson,Serena M. Bagnasco,Laura Barisoni,Elizabeth J. Brown,Daniel C. Cattran,Gaia M. Coppock,Katherine MacRae Dell,Vimal K. Derebail,Fernando C. Fervenza,Alessia Fornoni,Crystal A. Gadegbeku,Keisha L. Gibson,Larry A. Greenbaum,Sangeeta Hingorani,Michelle Hladunewich,Jeffrey B. Hodgin,Marie M. Hogan,Lawrence B. Holzman,J. Ashley Jefferson,Frederick J. Kaskel,Jeffrey B. Kopp,Richard A. Lafayette,Kevin V. Lemley,John C. Lieske,Jen Jar Lin,R. Menon,Kevin E.C. Meyers,Patrick H. Nachman,Cynthia C. Nast,Michelle M. O’Shaughnessy,Edgar A. Otto,Kimberly J. Reidy,K. Sambandam,John R. Sedor,Christine B. Sethna,Pamela Singer,Tarak Srivastava,Cheryl L. Tran,Katherine R. Tuttle,Suzanne Vento,Chia-shi Wang,Akinlolu O. Ojo,Dwomoa Adu,Debbie S. Gipson,Howard Trachtman,Matthias Kretzler +65 more
TL;DR: In this article , an unbiased transcriptomic-driven approach was used to identify molecular pathways which are shared by subgroups of patients with either minimal change disease (MCD) or focal segmental glomerulosclerosis (FSGS).
44
Defining the molecular correlate of arteriolar hyalinosis in kidney disease progression by integration of single cell transcriptomic analysis and pathology scoring
R. Menon,Edgar A. Otto,Laura Barisoni,Ricardo Melo Ferreira,Christine P. Limonte,Bradley Godfrey,Felix Eichinger,Viji Nair,Anitha S. Naik,Lakshmi Subramanian,Vivette D'agati,James M. Henderson,Leal Herlitz,Krzysztof Kiryluk,Dennis G. Moledina,Gilbert W. Moeckel,Paul M. Palevsky,C. Parikh,Pavneet Randhawa,Suzette Rosas,Astrid Rosenberg,Isaac E. Stillman,Robert D. Toto,Jose R. Torrealba,Miguel A. Vasquez,Sushrut S. Waikar,Chaiues E Alpers,Robert G. Nelson,Michael T. Eadon,Mathias Kretzler,Jeffrey B. Hodgin +30 more
TL;DR: In this article , the authors used single cell transcriptomic data and whole-slide images from kidney biopsies of patients with chronic kidney disease and acute kidney injury in the Kidney Precision Medicine Project to evaluate the molecular signals associated with arteriolar hyalinosis.
2
Role of endogenous adenine in kidney failure and mortality with diabetes
Kuldeepak Sharma,G Zhang,Jensen Hansen,Petter Bjornstad,H. J. Lee,R. Menon,Leila Hejazi,J.‐J. Liu,A.M. Franzone,Helen C. Looker,Bo Youl Choi,Ricardo Mendíola Fernández,Manjery A. Venkatachalam,Lakshmi Kugathasan,Vikas S. Sridhar,L. Natarajan,J. Zhang Z. Zhang,V. Sharma,BC-H Kwan,Sushrut S. Waikar,Jonathan Himmelfarb,K. Tuttle,Bryan Kestenbaum,Tobias Fuhrer,Harold I. Feldman,Ian H. de Boer,Fabio C Tucci,John R. Sedor,Hiddo J.L. Heerspink,Jennifer A. Schaub,Edgar A. Otto,Jeffrey B. Hodgin,Mathias Kretzler,Christopher Anderson,T. L. Alexandrov,David Z.I. Cherney,S C Lim,Robert G. Nelson,Jonathan Gelfond,Rajesh Iyengar,For the Medical Monitoring Project +40 more
TL;DR: In this article , a specific inhibitor of adenine production was found to reduce kidney hypertrophy and kidney injury in diabetic mice, and the authors proposed that endogenous adnine may be a causative factor in kidney disease.
Wcn23-0471 the enhancement of metallothionein bind metal pathway with sglt2 inhibitors in kidney proximal tubules of adolescents with type 2 diabetes using single cell rna-seq data
Fadhl M. Al-Akwaa,Patrick McCown,Aarti Naik,Jennifer A. Schaub,R. Menon,Elke Otto,Viji Nair,Sean Eddy,Louisa T Pyle,Johan Hartman,J. C. Hodgin,Robert G. Nelson,F. Brosius Division,Mathias Kretzler,Petter Bjornstad +14 more